相关实验视频

Updated: Jul 8, 2025

Dual Immunofluorescence of γH2AX and 53BP1 in Human Peripheral Lymphocytes

Dual Immunofluorescence of γH2AX and 53BP1 in Human Peripheral Lymphocytes

Published on: July 14, 2023

布莱奥米辛通过DNA-PKcs/阿尔特米斯介导的DNA断裂修复途径促进rAAV2转导

Xiaoping Huang¹, Xiao Wang², Yaqi Sun³

¹College of Chemical Engineering and Materials Sciences, Quanzhou Normal University, Quanzhou, China; Institute of Molecular Medicine, Huaqiao University, Quanzhou, China.

|December 15, 2023

概括

布莱米辛通过提高转导效率来增强复合腺相关病毒 (rAAV) 基因疗法. 这种化疗药物通过帮助第二链合成和减少颗粒降解,在体内和体外增强了rAAV传递.

科学领域:

基因治疗基因治疗
分子生物学分子生物学
在瘤学瘤学.

背景情况:

再组合腺相关病毒 (rAAV) 由于其安全性和简单的基因组,是体内基因治疗的有希望的载体.
在某些细胞类型中,rAAV的低转导效率限制了其在基因治疗中的更广泛应用.
美国食品和药物管理局 (FDA) 批准的化学疗法剂白素对rAAV转导的影响仍未得到研究.

研究的目的:

系统地研究白素对rAAV传导效率的影响.
阐明白素影响rAAV第二链合成和DNA修复途径的机制.
探索将白素与rAAV结合用于增强基因疗法的潜力,特别是在瘤学中.

主要方法:

利用CRISPR/Cas9和RNA干扰 (RNAi) 技术研究白素对rAAV转导的影响.
评估了白素对rAAV第二链DNA合成的影响.
研究了包括TDP1,PNKP和SETMAR在内的DNA修复酶在白氨酸中介增强rAAV转导中的作用.
研究了白素对DNA-PKcs酸化的影响及其对第二链合成的下游影响.

主要成果:

布莱奥米辛在体内和体外都显著促进了rAAV2转导.
增强的转导归因于减少了rAAV颗粒的细胞质降解和增加了第二链DNA合成.
TDP1,PNKP和SETMAR对于修复白素诱导的DNA损伤和促进rAAV第二链合成至关重要.
布莱米辛诱导DNA-PKcs酸化,与阿尔特米斯的酸化复合物增强了第二链合成.

结论:

布莱米为体内和体外基因治疗应用提供了一种新的策略,以提高rAAV转导效率.
这项研究提供了一种机理性的理解,即白素如何通过DNA修复途径影响rAAV矢量学.
这些发现表明,当将白素化疗与基于rAAV的瘤基因治疗相结合时,可能会产生协同效应.

关键词:

亚特米斯 (Artemis) 是一个神奇的生物.布莱莫辛是一种白色素.修复DNA的修复DNA的修复这就是DNA-PKcscs.第二链DNA合成 rAAAVAV 在这里.

更多相关视频

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin

Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin

Published on: April 30, 2019

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Pre-Conditioning the Airways of Mice with Bleomycin Increases the Efficiency of Orthotopic Lung Cancer Cell Engraftment

Published on: June 28, 2018

相关概念视频

Mutations

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Long-patch Base Excision Repair

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:

Nucleotide Excision Repair

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

The Intrinsic Apoptotic Pathway

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...